Arctoris is a biotech services company based in Oxford, Singapore and Boston that applies laboratory automation and computational approaches to accelerate drug discovery from target to candidate. The team of 40+ spans cellular, molecular and structural biology, biochemistry and biophysics, machine learning and cheminformatics, as well as clinical strategy and market access consulting. Arctoris works with leading biotech and pharma, as well as the most prominent AI drug discovery companies worldwide to deliver effective drug discovery R&D projects. Arctoris' underlying philosophy is that better data leads to better decisions, leads to better drugs. 

Our laboratories at the Research Complex at Harwell are ideally situated close to the Diamond Light Source and are central to our protein science, biophysics and structural biology research areas. These disciplines are part of Arctoris' broad integrated drug discovery capabilities, enabling us to deliver projects from target ID to advanced drug candidates.

Our protein science, structural biology and biophysics team hail from institutions such as Lonza, Evotec, Immunocore and the University of Oxford. The team is led by Dr Rahul Yadav, former protein science team leader at Evotec.

Arctoris works on a multiplicity of research projects and collaborations spanning numerous therapeutic areas and modalities. Arctoris is open to collaboration with research groups, and companies from small startups to large public organisations.


recent updates

Recent Updates
26 May 2023

Arctoris and Synthego announce CRISPR Drug Discovery